Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.fiercepharma.com/manufacturing/89bio-lines-china-cdmo-build-api-plant-commercial-production-mash-candidate
https://www.globenewswire.com/news-release/2024/04/05/2858731/0/en/89bio-Announces-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html
https://www.pharmaceutical-technology.com/news/89bio-wins-ema-priority-status-for-mash-candidate-pegozafermin/
https://www.globenewswire.com/news-release/2024/03/27/2853082/0/en/89bio-Receives-EMA-PRIME-Status-for-Pegozafermin-in-the-Treatment-of-Metabolic-Dysfunction-Associated-Steatohepatitis-MASH-with-Fibrosis-and-Compensated-Cirrhosis.html
https://www.globenewswire.com//news-release/2024/03/12/2844476/0/en/89bio-Initiates-Phase-3-ENLIGHTEN-Fibrosis-Trial-of-Pegozafermin-in-Non-Cirrhotic-Metabolic-Dysfunction-Associated-Steatohepatitis-MASH-Patients-with-Fibrosis.html
https://www.globenewswire.com/news-release/2024/03/08/2843322/0/en/89bio-Announces-Inducement-Grant-Under-Nasdaq-Listing-Rule-5635-c-4.html
https://www.globenewswire.com//news-release/2024/03/05/2840888/0/en/89bio-to-Participate-in-the-Leerink-Partners-Global-Biopharma-Conference.html
https://www.globenewswire.com//news-release/2024/02/29/2838404/0/en/89bio-Reports-Fourth-Quarter-and-Full-Year-2023-Financial-Results-and-Provides-Corporate-Updates.html
https://www.globenewswire.com//news-release/2024/02/06/2824708/0/en/89bio-to-Participate-in-the-Oppenheimer-34th-Annual-Healthcare-Life-Sciences-Conference.html
https://www.globenewswire.com//news-release/2024/02/05/2823845/0/en/89bio-Announces-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html